Zoetis Services LLC

Christopher A Zook

Rebecca R Quesnell

Richard Andrew Ewin

Bruktawit T Asfaw

Fiona Patricia Carney

Sumitra Rajagopalan

Michael T Sweeney

Wilms Baille

Piotr Kujawa

Derek James Sheehan

Eric Baima

Stephen Lee Secreast

Laibin Luo

Dennis L Huczek

Claude-Raymond René

Sarah Barbara Kokotoff

Dominic Dominicovich Ugbedah

Michael Kuhn

Fiona Patricia Clements

Tammy A Sanders

Hilary Phelps

Claude-Raymond Rene

Bruktawit Asfaw

Stephen L Secreast

Antimicrobial peptides of general formula XXXCXXXCXXXXCYXXCXX(SEQ ID NO: 12) are provided. Also provided are certain formulations containing these peptides and methods of using these peptides for treating skin infections in an animal in need thereof.

Antimicrobial peptides and methods of using same

Antimicrobial peptides of general formula XXXC XXXCXXXXCYXXCXXare provided. Also provided are certain formulations containing these peptides and methods of using these peptides for treating skin infections in an animal in need thereof.

The present disclosure relates generally to sol-gel polymer composites that comprise chitosan, a hydrophilic polymer, a gelation agent, and optional additional ingredients in a suitable medium. Advantageously, the sol-gel polymer composite can form a durable seal or strong solid in response to one or more physiological stimulus. The disclosure further relates to medical and veterinary uses of the composite, particularly, methods and delivery systems for reducing or preventing the incidence of a mammary disorder in a dairy animal. More particularly, the disclosure includes methods and sol-gel polymer composite compositions for creating a physical barrier on the teat surface or in the teat canal or cistern of a non-human animal for prophylactic treatment of mammary disorders such as mastitis wherein the sol-gel polymer creates a seal in response to one or more physiological stimulus.

Sol-gel polymer composites and uses thereof

The present disclosure relates to methods, compositions, and devices for treatments related to mammary tissue in subjects, including reducing the incidence of mastitis. In particular, the disclosure can relate to creating a physical barrier on a teat surface, in a teat canal, or in a teat cistern for prophylactic treatment of mammary disorders.

Hydrogel formulation with mild adhesion

Growing community of inventors

Kalamazoo, MI, United States of America

Christopher A Zook